Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- SIOXDELISTED
- Price
- -
- Stock movement up
- +- (0.00%)
- Company name
- Sio Gene Therapies Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 30.43M
- Ent value
- -13.54M
- Price/Sales
- -
- Price/Book
- 0.67
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -41.72%
- 1 year return (CAGR)
- 8.26%
- 3 year return (CAGR)
- -42.46%
- 5 year return (CAGR)
- -42.85%
- 10 year return (CAGR)
- -
Last updated: 2024-12-17
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
SIOX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.67 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 73.98M |
| EPS (TTM) | -0.39 |
| FCF per share (TTM) | -0.69 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -29.37M |
| Net income (TTM) | -28.83M |
| EPS (TTM) | -0.39 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 46.13M |
| Net receivables | 356.00K |
| Total current assets | 47.27M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 47.27M |
| Accounts payable | 201.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.15M |
| Total liabilities | 2.15M |
| Shareholder's equity | 45.12M |
| Net tangible assets | 45.12M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -50.27M |
| Capital expenditures (TTM) | 939.00K |
| Free cash flow (TTM) | -51.21M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -63.89% |
| Return on Assets | -60.99% |
| Return on Invested Capital | -63.89% |
| Cash Return on Invested Capital | -113.50% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
No data
Stock price data
| Open | 0.41 |
| Daily high | 0.41 |
| Daily low | 0.41 |
| Daily Volume | 0K |
| 1y analyst estimate | 5.00 |
| Beta | 1.08 |
| EPS (TTM) | -0.39 |
| Dividend per share | - |
| Ex-div date | 8 Feb 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SIOX | S&P500 | |
| Current price drop from All-time high | -99.80% | -4.34% |
| Highest price drop | -99.88% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -81.00% | -10.84% |
| Avg time to new high | 291 days | 12 days |
| Max time to new high | 1752 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
30.43M
Marketcap category
Small-cap
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
Employees
12
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page